BridgeBio Pharma (BBIO) Cash & Equivalents (2018 - 2026)
BridgeBio Pharma's Cash & Equivalents came in at $677.91 million for Q2 2026, down 9.5% from $748.95 million a year earlier and down 23.0% from the prior quarter.
Powered by 
Analysis
BridgeBio Pharma (BBIO) Cash & Equivalents (2018 - 2026) Analysis & Trends
At the end of FY2025, BridgeBio Pharma's Cash & Equivalents was $570.12 million, down 16.3% from FY2024.
- Cash & Equivalents carries a five-year compound annual growth rate of 9.9% (FY2020 to FY2025).
- Going back by year, Cash & Equivalents was $681.1 million in FY2024 (+81.2%), $375.94 million in FY2023 (-0.2%), $376.69 million in FY2022 (-4.3%) and $393.77 million in FY2021 (+10.6%).
- The five-year range for quarterly Cash & Equivalents is $180.35 million (Q3 2021) to $879.89 million (Q1 2026).
- Year-over-year, Cash & Equivalents increased in five of the last eight quarters, with growth averaging 38.7%.
- The fastest year-over-year change in Cash & Equivalents over five years came in Q3 2022 (growth of 167.9%), and the weakest in Q3 2021 (a decline of 50.9%).
- Business Quant data shows BBIO's Cash & Equivalents at $879.89 million (Q1 2026), $570.12 million (Q4 2025) and $642.95 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 20.42 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 6.57 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 6.85 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 7.62 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 4.89 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 13.99 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 3.18 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 976.00 Mn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 6.14 Bn |
| 10 | BridgeBio Pharma | 12.85 Bn | 9.97 Bn | 228.63 Mn | 677.91 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 677.91 Mn |
| Mar 31, 2026 | 879.89 Mn |
| Dec 31, 2025 | 570.12 Mn |
| Sep 30, 2025 | 642.95 Mn |
| Jun 30, 2025 | 748.95 Mn |
| Mar 31, 2025 | 540.60 Mn |
| Dec 31, 2024 | 681.10 Mn |
| Sep 30, 2024 | 266.32 Mn |
| Jun 30, 2024 | 407.96 Mn |
| Mar 31, 2024 | 475.22 Mn |
| Dec 31, 2023 | 375.94 Mn |
| Sep 30, 2023 | 505.21 Mn |
| Jun 30, 2023 | 302.44 Mn |
| Mar 31, 2023 | 407.37 Mn |
| Dec 31, 2022 | 376.69 Mn |
| Sep 30, 2022 | 483.24 Mn |
| Jun 30, 2022 | 470.10 Mn |
| Mar 31, 2022 | 371.55 Mn |
| Dec 31, 2021 | 393.77 Mn |
| Sep 30, 2021 | 180.35 Mn |
API Access
BridgeBio Pharma Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=BBIO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "BBIO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=BBIO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();